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Abstract
Background: Deep brain stimulation (DBS) for refractory psychiatric disorders 
shows promising effects on symptom-reduction, however, little is known regarding 
the effects of DBS on social outcome.
Methods: A PubMed search based on original studies of DBS for psychiatric 
disorders [treatment resistant depression (TRD), Gilles de la Tourette’s syndrome 
(GTS), and obsessive compulsive disorder (OCD)] was conducted. Data on social 
outcome following surgery were extracted and analyzed.
Results: Social functioning was not a primary outcome measure in the reviewed 
article. The literature is incomplete and inconclusive on this variable, however from 
the reported data, there is some evidence that DBS has the potential to improve 
social functioning.
Conclusions: More systematic and detailed data gathering and reporting on social 
outcome with longer follow-ups are needed to evaluate more exhaustively the role 
of DBS in refractory psychiatric disorders.
Key Words: Deep brain stimulation, Gilles de la Tourette’s syndrome, obsessive 
compulsive disorder, refractory psychiatric disorders, social outcome, treatment 
resistant depression
INTRODUCTION
Deep brain stimulation (DBS) is considered a safe and 
established treatment option with the advantages of 
being nondestructive, reversible, and adjustable. The 
renaissance of DBS dates to 1987, when the French 
group led by Benabid applied DBS for refractory 
motor disease,[3] while the end of the 1990s saw the 
first applications of DBS for refractory psychiatric 
disorders. In 1999, the pioneering papers on DBS for 
refractory Gilles de la Tourette’s syndrome (GTS) and 
obsessive compulsive disorders (OCD) were published, 
respectively, by the Dutch group led by Vandewalle[42] 
and by the Belgian group of Nuttin et al.[24] Six years 
later appeared the work of the US-Canadian team of 
Mayberg and Lozano for DBS in refractory depression.[23] 
Since then, multiple smaller open studies were published 
showing promising results with an overall response rate of 
30–50%.[35] Much focus in the evaluation of the effectivity 
of DBS is placed on the reduction of symptoms, whereas 
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limit. Only articles in English language were selected. 
The search was based on the current three main DBS 
indications for refractory psychiatric disorders, treatment 
resistant depression (TRD), GTS, and OCD. Key words 
used were “deep brain stimulation” in combined fashion 
with “Gilles de la Tourette’s syndrome,” “obsessive 
compulsive disorder,” and “depression.” Only original 
studies, case reports/case series were included. Reviews, 
commentaries and basic research studies were excluded. 
Further articles were identified via an analysis of relevant 
papers obtained from the first literature search. From 
the initial search, we considered 87 papers for the first 
analysis. All papers on DBS for psychiatric disorders were 
reviewed at this stage for the outcome measure of social 
functioning; only articles reporting on this variable were 
considered for final analysis. Thirty two articles were 
included for our study: 11 GTS studies, 13 OCD  studies, 
and 8 TRD studies. For each psychiatric indication, the 
data on demographics, the clinical results of DBS and the 
effect on social behavior were extracted, tabulated, and 
analyzed [Tables 1–3]. The data related to social behavior 
was reported quantitatively or qualitatively. Studies that 
little is known as to the social impact of DBS for 
psychiatric disorders. Social functioning is a key outcome 
in young patients with neurodevelopmental psychiatric 
condition.[7,27,37] The improvement of social skills and 
functioning is crucial for the long-term outcome of 
psychiatric disorders with an early age of onset. Social 
integration and social support belong to the strongest 
correlates of a healthy psychological development. Even 
psychotherapy trials show that psychosocial interventions 
results in only small to moderate improvements in social 
outcomes, and that these improvements are associated 
with, but not fully explained by symptom reduction.[32] 
There is no review paper investigating the relation DBS 
in refractory psychiatric disorders and social functioning. 
With this study, we aimed therefore at elucidating the 
effects on social functioning of DBS for psychiatric 
disorders.
MATERIALS AND METHODS
A PubMed search based on original studies of DBS for 
psychiatric disorders was conducted without any time 
Table 1: Deep brain stimulation in Gilles de la Tourette syndrome
Authors (Year) Sample 
Size
Gender 
(f, m)
Age (y) Disease 
duration (y)
Comorbidities FU (m) YGTSS - % 
reduction
YBOCS: % 
change
Social function 
(Scale)
Reference
Sachdev (2014) 17 3, 14 29 NM NM 24 45 N/A GAF: Pre-DBS: 50, 
Post-DBS: 72
[34]
Porta (2009) 15 3, 12 30 FU NM 24 51.9 46.4 SSI-VAS mean pre/
post: 8.4/5.8
[29]
Cannon (2012) 11 3, 8 33 23 1. SIB
2. Coprolalia
3. OCD
4. Anxiety
3 48.8 56.2 GAF: Pre-DBS: 47, 
post-DBS: 75
[5]
Huys (2016) 8 5 33 NM OCD 12 51 No significant 
effect
GAF: Pre-DBS: 66, 
post-DBS: 74
[15]
Dehning (2012) 6 3, 3 34 27.5 NM 32 4 responders 
(2 nonresponders)
N/A GAF: Pre-DBS: 54, 
post-DBS: 84
[8]
Kaido (2010) 3 2, 1 20 8.6 NM 12 36.1 0.0 YGTSS, pre-/
post-DBS (part 3):
Pt 1: 50/30
Pt 2: 30/20
Pt 3: 40/20
[10]
Servello (2009) 4 1, 3 35 NM OCD 13 64.6 30.3 NM [39]
Welter (2008) 3 2, 1 32 23.3 1. MDD, SIB, 
BPD
2. GAD
60 TA: 64, 30, 40
Gpi: 65, 96, 74
TA+Gpi: 60, 
43, 76
N/A NM [44]
Shahed (2007) 1 0, 1 16 13 1. OCD
2. ADHD
3. Coprolalia
4. Depression
4 76.0 69.9 NM [40]
Lee (2011) 1 0, 1 31 24 No 18 58.0 N/A NM [19]
Zekaj (2015) 1 0, 1 17 10 ADHD 96 95% NM NM [45]
GTS: Gilles de la Tourette syndrome, m: male, f: female, NM: Not Mentioned, OCD: Obsessive Compulsive Disorder, SIB: Self-Injury Behaviour, BPD: Borderline Personality 
Disorder, TA: Thalamus, Gpi: Globus pallidus internus, N/A: Not applicable, ADHD: Attention Deficit Hyperactivity Disorder, PT: Patient, YGTSS: Yale Global Tic Severity Scale, 
YBOCS: Yale Brown Obsessive Scale
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reported quantitative data as to social functioning are 
listed in the tables first, followed by studies that did not 
provide the data as to social functioning. Qualitative 
data in form of comments of the authors we reported 
verbatim. For each group the mean values for age, disease 
duration, sample-size, and follow-up period with standard 
deviation (SD) were calculated. The precise degree of 
overlap of cohorts reported in serial papers was not always 
specified. Therefore, for the reported mean values only 
approximations could be indicated. Studies are tabulated 
in order of decreasing sample size. The analyzed findings 
were organized in the results section. Studies that 
reported in more detail on social behavior were presented 
in a separate section “DBS and social behavior” classified 
equally into the three main psychiatric indications and 
listed in the same order as tabulated.
RESULTS
The studies included in our analysis included 236 patients: 
70 GTS patients, 88 OCD  patients, and 78 TRD 
patients [Tables 1–3]. Considering the great heterogeneity 
of data reporting, the small sample sizes, methodological 
limitations, the absence of control groups, an exhaustive 
and balanced comparison, and evaluation of the effects of 
DBS on social function remained challenging. The literature 
remained inconclusive in predicting the social outcome 
following DBS. Different scales in evaluating social impact 
Table 2: Deep brain stimulation in obsessive compulsive disorder
Authors (Year) Sample 
Size
Gender 
(f, m)
Age 
(y) 
Disease 
Duration 
(y)
Comorbidities Follow-up 
(max., in 
months)
1° Outcome 
scale 
(Y-BOCS)
% change 
(at latest 
follow-up)/
mean (SD) 
>1 pts
Social function 
(Scale)
References
Mallet (2008) 17 7, 10 43 18 NM 10 Y-BOCS 36 GAF: Baseline 39, 
End of On period: 52
[21]
Ooms (2014) 16 7, 9 45 26 NM 12 Y-BOCS 41 GAF No significant 
change
[26]
Denys (2010) 16 7, 9 42.5 28.3 1. MDD
2. Mild anxiety
12 Y-BOCS 46 Sheehan Disability 
Scale: Improved
[9]
Huff (2010) 10 4, 10 36.3 22.2 NM 12 Y-BOCS 31.2 GAF mean pre-DBS: 
36.6, mean 
post-DBS: 53.1 
[14]
Greenberg (2006) 10 4, 6 35.3 22.5 MDD 36 Y-BOCS 35 GAF: Pre-DBS: 36.6; 
post-DBS: 53.8
[12]
Tsai (2012) 4 0, 4 25.5 8.3 MDD 15 Y-BOCS 33 GAF: Pre-DBS: 43.5, 
Post-DBS 57.0
[41]
Chabardès (2012) 4 2, 2 38.2 20.5 NM 6 Y-BOCS 64.5 GAF mean pre-DBS: 
33.5; mean 
post-DBS: 72
[6]
Roh (2012) 4 1, 3 33.7 16.8 MDD 24 Y-BOCS 59.4 GAF: Mean pre-DBS: 
44.0
[33]
Servello (2009) 4 1, 3 35 NM GTS 51 Y-BOCS 36 VAS: Baseline: 10.0, 
last FU: 7.0
[39]
Abelson (2004) 4 2, 2 40.2 22.5 1. MDD
2. Social phobia
3. Tic disorder
4. BDD
5. Anorexia/
Bulimia
23 Y-BOCS 32.7 GAF mean pre-DBS: 
31.7, mean 
post-DBS: 52.5
[1]
Franzini (2010) 2 0, 2 37 21 1. BP
2. BDD
3. Phobic anxiety
4. MDD
27 Y-BOCS 37.5 GAF: Pt 1 pre-DBS: 
40, post-DBS: 60; 
Pt 2 pre-DBS: 40, 
post-DBS: 60
[10]
Aquizerate (2004) 1 1 56 40 MDD 15 Y-BOCS 44.0 GAF: Pre DBS: 35, 
post- DBS: 60
[2]
Jiménez (2013) 6 NM 34.6 16 1. Drug addiction
2. Schizoid PD
12 Y-BOCS 51 NM [17]
m: male, f: female, NM: Not Mentioned, DBS: Deep brain stimulation, GTS: Gilles de la Tourette’s syndrome, GAF: Global Assessment of Functioning, FU: Follow-up, m: months, 
y: years, MDD: Major depressive disorder, BDD: Body dysmorphic disorder, YBOCS: Yale Brown Obsessive Compulsive Severity Scale, VAS: Visual analog scale
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were used across studies. Further, the social impact of DBS 
was not uniformly reported for each patient within the 
same study; the authors detailed social outcomes mainly for 
patients where a difference in social behavior after DBS was 
observed. Therefore, we provided alongside the quantitative 
data verbatim the comments of the authors as to social 
functioning, so that the reader can form his own opinion.
Gilles de la Tourette
Eleven GTS studies were included [Table 1]. For the 
GTS group the mean age of patients was 28.1 years (SD 
7.0), with a mean disease duration of 18.5 years (SD 7.6). 
The mean sample-size was 6.3 participants (SD 5.7) per 
study with a mean follow-up of 27 months (SD 27.7).
Obsessive compulsive disorder
13 OCD  studies were included [Table 2]. The mean age 
of the OCD group was 38.3 years (SD 7.3). The mean 
sample size was 7.5 participants (SD 5.6) per study with 
a mean disease duration of 21.9 years (SD 7.7) and a 
mean follow-up of 19.6 months (SD 12.5).
Treatment resistant depression
Eight TRD studies were included [Table 3]. The TRD 
group had a mean age of 45.8 years (SD 2.7) and a mean 
disease duration of 18.7 years (SD 5.0). The mean sample 
sizes were 12.2 participants (SD 6.9) per study with a 
mean follow-up of 23.5 months (SD 13.4).
Deep brain stimulation and social functioning
Deep brain stimulation and social functioning in Gilles de la 
Tourette’s syndrome
In a cohort of 17 patients Sachdev et al.[34] noted that 
patients improved on all secondary measures. The authors 
wrote, “The wide ranging impact of TS on sufferers 
is well known, and although almost all our patients 
continued to display clinically relevant symptomatology, 
it is notable that the degree of improvement noted with 
DBS in these patients leads to significant gains in their 
day to day lives. Modest gains noted on symptom rating 
scores, often translate into greater functional gains, 
reflective of the high pretreatment severity of illness in 
such DBS cohorts. This is reflected more accurately 
in the improvements noted in the quality of life, and 
functional status ratings of this cohort for responders and 
the majority of non-responders alike.”
Dehning et al.[8] wrote, “Although at first view it appears 
self-evident that an improvement in symptomatic 
outcome will be accompanied by an improvement 
in functional outcome, in other psychiatric disorders 
symptomatic improvement often leaves persistent 
impairment in social functioning. Our data suggest that 
once DBS-induced remission is achieved in TS patients, 
the patients remain in remission in the long-term and 
thus can regain social functioning, including building a 
partnership and findings a regular employment.”
The results of a 2-year follow-up on 15 patients were 
published by Porta et al. in 2009.[29] DBS led to a 
52% tic reduction on the Yale Global Tic Severity 
Scale (YGTSS) and to a 46% percentage change on 
the Yale Brown Obsessive Compulsive Scale (YBOCS). 
The mean Subjective Social Impairment-Visual Analog 
Scale (SSI-VAS) decreased postoperatively from 8.4 to 5.8. 
The authors reported, “The subjective perception of 
social impairment improved in 14 of 15 patients.”
In 2009, this same group from Milan used nucleus 
accumbens DBS in four patients, who had failed to 
respond to thalamic or pallidal DBS.[39] A tic reduction 
of 65% on the YGTSS was observed. For one patient, the 
Table 3: Deep brain stimulation in treatment refractory depression
Authors (Year) Sample 
Size
Gender 
(f, m)
Age 
(y)
Disease 
Duration 
(y)
Comorbidities FU 
(m)
Response/remission 
(at latest follow-up)
Social function (Scale) References
Kennedy (2011)* 20 FU FU FU FU 36, 72 64.3% 
response/42.9% 
remission
SF-36: Pre-DBS: 48, Post-DBS: 71 [18]
Lozano (2008) 20 11, 9 47.4 20.3 No 12 55% response/35% 
remission
Unemployment pre-DBS: 18/20 
Unemployment 12m post-DBS: 
12/20
[20]
Holtzheimer (2012) 17 10, 7 42.0 22 NM 24 92% response/58% 
remission
GAF: Baseline (17 pts): 33.9 (1.7); 
2 years post-DBS: 78.7 (4.1)
[13]
Malone Jr (2008) 15 11, 4 46.3 21.0 NM 48 53% response/40% 
remission
GAF: Baseline 43.4 (2.8), last FU: 
61.8 (13.1)
[22]
Schlaepfer (2013) 7 3, 4 42.6 7.6 NM 8 6 pts responders (4 
remitters)
GAF: Baseline: 42.8 (SD 11), 
post-DBS: 61 (SD 8.9)
[38]
Bewernick (2010) 10 4, 6 48.6 17 NM 24 50% response NM [4]
Puigdemont (2012) 8 6, 2 47.4 22.5 NM 12 62.5% response/50% 
remission
NM [30]
m: male, f: female, NM: Not Mentioned, DBS: Deep brain stimulation, HDRS: Hamilton Depression Rating Scale, GAF: Global Assessment of Functioning, FU: Follow-up, m: months, 
y: years, SF-36: 36-item Short-Form Health Survey Questionnaire (SF-36), *Kennedy et al. 2011 patients reported previously in Lozano et al. 2008
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authors observed, “He had many years which included 
difficulty in integrating into society, and he had many 
admissions to neurologic and psychiatric wards as a result 
of highly aggressive behavioral outbursts with multiple 
complex motor tics.” After DBS “the patient was able to 
reintegrate into society, and was able to independently 
operate a car. His drug therapy was discontinued, and he 
maintained an ability to stay gainfully employed.”
Welter et al.[44] commented on an important tic reduction 
with pallidal and thalamic stimulation, while motor 
symptoms reoccurred during sham stimulation in three 
patients with a mean age of 32 years and a mean disease 
duration of 23 years. The patients presented multiple 
comorbidities, such as major depressive disorder (MDD), 
self-injury behavior (SIB), borderline-personality 
disorder (BPD), and generalized anxiety disorder (GAD). 
One patient returned 2 years after DBS to full-time work 
and began interpersonal psychotherapy, which enabled an 
improvement in interpersonal relationships. The second 
patient “did not recover his professional activity, while 
the third patient began (4 months after the end of the 
protocol) a professional educational retraining program.”
A 76% tic reduction on the YGTSS and to a circa 70% 
change on the YBOCS in a 16-year-old male patient 
was recorded by Shahed et al.[40] The patient had 
several comorbidities, such as OCD, attention deficit 
hyperactivity disorder (ADHD), coprolalia, and depression. 
The patient was academically and socially impaired 
before DBS. After DBS a “mild social introversion and 
withdrawal remained.” The authors concluded that 
“the persistent social avoidance may have resulted from 
learned/reinforced presurgical behavior patterns.”
Lee et al.[19] observed in one 31-year-old patient with a 
disease duration of 24 years, an important tic reduction 
following DBS. “Our patient was unemployed because of 
tics before the surgery. With improvement in his tics, he 
managed to find a job about a year after the surgery.”
Zekaj et al.[45] commented on an interesting case of a 
young Tourette syndrome (TS) patient treated with 
DBS at the age of 17. The patient was followed up for 
96 months. As the patient showed a stable clinical 
picture in off-condition for 2 years the whole DBS device 
was removed. “Before DBS, our patient was not able to 
confront the challenges of school and had to leave without 
qualification. After DBS he had an optimal professional 
formation and social insertion in the most crucial period 
of his young adult life.” The authors proposed to consider 
DBS in TS as a “bridging therapy” to pass successfully the 
difficult period of a young adult life.
Deep brain stimulation and social functioning in obsessive 
compulsive disorder
Greenberg et al.[12] reported on 10 OCD patients with 
a mean age of 35 years and a mean disease duration 
of 23 years. From the 10 included patients eight were 
followed up, one died 9 months after DBS (cancer), and 
one was followed up to 24 months with a 35% YBOCS 
change at latest follow-up. The Global Assessment of 
Functioning (GAF) increased from a mean 37 (SD 1.5) 
pre-DBS to 54 (SD 2.5) post-DBS. “No patient was 
working or in school before DBS; six were during 
chronic stimulation. Ability to perform activity of daily 
livings (ADLs) independently was markedly impaired in 
seven patients at baseline; this was true of one patient 
during DBS. No patient lived independently before DBS, 
whereas six did so afterwards. With the exception of 
the patient who died owing to recurrent breast cancer 
9 months after implantation, social engagement improved 
in eight of nine patients, to varying degrees ranging from 
greater social contact to becoming engaged to marry.”
Jiménez et al.[16] noted in six OCD patients with a mean 
disease duration of 16 years that “during the stimulation 
period, all patients improved their relationships with 
their family and social environment. To date, two of the 
patients are employed.”
Chabardès et al.[6] treated four OCD patients with 
DBS. The resulted improvement allowed “a professional 
reintegration perspective and improving his social and 
family function.”
Roh et al.[33] followed-up for 24 months four patients 
with OCD and observed “individual interviews represent 
a change from serious impairment in social, occupational, 
or school functioning to generally normal function and 
having some social relationships.”
Abelson et al.[1] reported in one out of four patients 
with multiple associated comorbidities treated with 
DBS an initial positive impact on social outcome. The 
patient “returned to work for the first time in over a year. 
However, 2 months later, she left the new job because of 
intensifying depression and stress, and she committed 
suicide shortly thereafter. She left a note stating that her 
OCD was still improved and that her suicide was due to 
depression and unrelated to the study.”
Deep brain stimulation and social functioning in treatment 
resistant depression
Kennedy et al.[18] published the follow-up of 20 patients 
previously reported by Lozano et al. (2008) and Mayberg 
et al. (2005). “The rate of employment at the time of 
DBS surgery was 10%. The rate increased to 50% by 
year 1 and onward. Three patients also began doing 
volunteer work, resulting in 65% of patients being 
engaged in work-related activities. Those who responded 
to treatment were more likely to return to work (90.9% of 
those who responded, compared with 33.3% of those who 
did not, P < 0.05; odds ratio = 20.95; CI = 1.7–238.6).”
Lozano et al.[20] followed-up for 12 months 20 patients 
with refractory depression. A 55% response rate was 
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observed and 35% of patients remitted. Eighteen out 
of the 20 patients were unemployed prior to DBS while 
this number 1 year post-DBS dropped to 12. “Six of 
17 patients who were not working due to their illness 
at enrolment returned to employment after being 
unemployed for 2–7 years, indicating that DBS led to 
significant social reintegration.”
Holtzheimer et al.[13] published interesting results on 
17 patients with a mean age of 42 years and a mean disease 
duration of 22 followed-up for 2 years. DBS led to a 92% 
response rate with a 58% remission rate. The GAF scale 
improved in all patients, suggesting that the treatments 
had also beneficial effects on social functioning [GAF: 
Baseline (17 patients): 33.9 (SD 1.7); 2 years post-DBS: 
78.7 (4.1)]. Fourteen out of the 17 patients were unable 
to work prior to DBS. Regrettably no mentioning as to 
their working capacity in the postoperative setting was 
made; the GAF rates on a scale between 0 and 100, with 
lower scores reflecting worse status the psychological, 
social, and occupational functioning.
Bewernick et al.[4] published the results on 10 patients 
with a response rate of 50% response following DBS. 
“Fifty percent of patients had never reached remission 
status since first diagnosis and all were retired from work 
due to depression.” With respect to the DBS treatment 
response they stated, “Although the effect varied between 
patients, substantial positive changes in clinical symptoms 
and social life (e.g., returning to work part time, starting 
a new hobby, establishing a daily structure, and making 
new acquaintance) were observed in all patients.”
Puigdemont et al.[30] followed-up for 1 year eight patients 
with a mean age of 47 years and a mean disease duration 
of 23 years. A mean 63% response rate was observed. 50% 
of patients remitted. The authors wrote: “At the time of 
writing the majority of patients have recovered, or even 
started leisure activities and social relationships, after having 
been inactive due to their depressive illness for several years 
prior to intervention. Additionally, two patients no longer 
require daily support. These are indicators that DBS would 
also enhance the psychosocial functioning.”
DISCUSSION
The reviewed literature showed a significant variability 
in many factors including number of patients, mean 
age, comorbidities, disease duration, follow-up periods, 
and evaluating scales. Analyzing in a systematic and 
organized manner the available data allowed, however, 
despite the aforementioned encountered limitations, 
to appreciate certain patterns of the impact of DBS on 
social functioning.
Based on the available literature, DBS in refractory 
psychiatric disorders seems to have the potential to 
improve social functioning.
The modern era of DBS has made significant advances 
in treating refractory psychiatric respect the beginnings of 
psychosurgery.[25,35] Several authors specified that patients 
who were unable to work before DBS were able to work after 
DBS[1,18-20,30,38,44,45] and improved overall social functioning. 
Many of these patients were severely disabled for many 
years by the disease (often associated with equally or even 
more disabling comorbidities) displaying severe social 
maladjustment (at interpersonal and at professional level). 
As a result, reported improvement of social functioning in 
these cohorts may be of great clinical relevance.
However, we cannot make definitive conclusions on the 
effects of DBS on social functioning based on the current 
data. The positive results have to be interpreted with great 
caution. We had to exclude a large number of patients 
treated with DBS for psychiatric disorders, approximately 
250, from our study since no data on social functioning 
were available. Within this context, one has to be bear in 
mind that authors may have avoided to report negative or 
neutral social outcomes, potentially leading to a selection 
bias in our considerations. In addition, sample sizes were 
too small (mean 8.3 participants per study, SD 3.2) to 
generalize findings. Studies focused more on symptom 
severity reduction than on social functioning. Data gathering 
on social impact was based on qualitative as quantitative 
approaches rendering a meaningful comparison of results 
between studies difficult. The social functioning showed 
also heterogeneity within the same study not allowing an 
analysis of different outcomes within the same study.
The data on GTS patients may be particularly difficult 
to interpret. Contrary to DBS for motor diseases in 
DBS for psychiatric disorders, targets are multiple. In 
GTS, the target choice is particularly complicated and 
heterogeneous given the great phenotypic variability of 
GTS.[28] Dehning et al.[8] write, “unlike in the ‘classical’ 
movement disorders, there does not seem to be ‘one’ 
target for DBS in TS: selected patients might respond 
to selected targets.” Given these methodological 
inconsistency and the aforementioned limitations in 
DBS reporting[36] our presented data does not allow to 
individuate any target that leads to more improvement 
in social functioning. Moreover, the studies in GTS 
had relatively short follow-up assessments (the mean 
follow-up period for the 236 included patients in our 
study was only 23.6 months, SD 3.5).
To fully evaluate the risks and benefits, including social 
functioning, of DBS in psychiatric disorders, several 
factors have to be systematically assessed: Severity of the 
treated patients refractory to any conventional psychiatric 
treatment, the natural disease course, the severe side 
effects of conventional treatment, the symptomatic 
improvement, and the social impact of DBS.
Social outcomes are particularly important in the 
assessment of therapeutic intervention in psychiatry. The 
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World Health Organization (1948) defines health as “a 
state of complete physical, mental and social well-being 
and not merely the absence of disease or infirmity.”[11] 
In addition, social deficits are frequently core aspects or 
important consequences of psychiatric conditions.
The assessment of social outcomes is not trivial. 
Unfortunately, there is no standard assessment. Social 
functioning includes multiple roles of an individual 
such as personal, social and professional interactions; it 
relates consequently directly to the quality of life of a 
participant.[32] These aspects should be considered when 
assessing social outcomes.
To evaluate more exhaustively the social outcomes of 
DBS, we recommend the use of the GAF and the Social 
Adjustment Scale.[43] It is important to be aware that 
symptom-severity improvement may not always translate 
into improved social functioning. The reasons for this 
lack of direct relationship are multiple. For example, 
social functioning does not solely relate to a participant’s 
physical and mental well-being, but equally to variables 
beyond the influence of medical treatment.
CONCLUSION
The current data on the social effects of DBS in 
psychiatric conditions is incomplete and inconclusive. 
However, from the available data DBS seems to have 
the potential to improve social functioning. Larger, 
multicentered trials are needed to increase statistical 
power, with systematic assessment of social outcomes 
along with longer follow-ups and closer postoperative 
surveillance, to evaluate more accurately the impact of 
DBS on social functioning.
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Commentary
We recommend our readers to pay attention to this 
excellent and organized review of the literature on the 
social impact of deep brain stimulation (DBS) for diverse 
applications in psychiatric disorders. The importance of 
this article is immense, as it criticizes the literature on 
the most important role of any therapy. Does DBS really 
impact on patients’ quality of life?
DBS will only be valuable as a therapy if it is 
scientifically shown that it impacts on the patients' 
quality of life, mostly bring the psychiatric patients to 
the main flow of society as productive citizens, or at 
least less dependent as possible. Although quantitative 
data are scarce, the positivity of the comments observed 
by the majority of the authors make DBS a valuable 
therapy for the scientific community to spend time 
sorting its real value. Those interested on behavior 
surgery, the discredit in the past psychosurgery, have to 
take the task of evaluating with critical scales reflecting 
adjustment of patients in their social environment in a 
strict scientific fashion.
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